Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Multi-National Gilenya Pregnancy Exposure Registry in Multiple Sclerosis

NCT01285479 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.

NCT NCT01285479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01285479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Multi-National Gilenya Pregnancy Exposure Registry in Multiple Sclerosis
Lead sponsor
Novartis Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
October 15, 2011
Completion date
May 29, 2024
Enrollment
312 (actual)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis